BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piras G, Grinblat G, Albertini R, Sykopetrites V, Zhong SX, Lauda L, Sanna M. Management of squamous cell carcinoma of the temporal bone: long-term results and factors influencing outcomes. Eur Arch Otorhinolaryngol 2021;278:3193-202. [PMID: 32979119 DOI: 10.1007/s00405-020-06378-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Daoudi H, Torres R, Mazalaigue S, Sterkers O, Ferrary E, Nguyen Y. Analysis of forces during robot-assisted and manual manipulations of mobile and fixed footplate in temporal bone specimens. Eur Arch Otorhinolaryngol 2021. [PMID: 33388980 DOI: 10.1007/s00405-020-06553-z] [Reference Citation Analysis]
2 Talukdar R, Epari S, Sahay A, Choudhari A, Dasgupta A, Chatterjee A, Gupta T. Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature. Eur Arch Otorhinolaryngol 2021. [PMID: 34410472 DOI: 10.1007/s00405-021-07047-2] [Reference Citation Analysis]
3 Nicoli TK, Atula T, Sinkkonen ST, Korpi J, Vnencak M, Tarkkanen J, Mäkitie AA, Jero J. Ear canal and middle-ear tumors: a single-institution series of 87 patients. Acta Otolaryngol 2022;:1-8. [PMID: 35148225 DOI: 10.1080/00016489.2022.2032824] [Reference Citation Analysis]
4 Zanoletti E, Franz L, Favaretto N, Cazzador D, Franchella S, Calvanese L, Nicolai P, Mazzoni A, Marioni G. Primary temporal bone squamous cell carcinoma: Comparing the prognostic value of the American Joint Committee on Cancer TNM classification (8th edition) with the revised Pittsburgh staging system. Head Neck 2022. [PMID: 35044004 DOI: 10.1002/hed.26980] [Reference Citation Analysis]
5 Borsetto D, Vijendren A, Franchin G, Donnelly N, Axon P, Smith M, Masterson L, Bance M, Saratziotis A, Polesel J, Boscolo-Rizzo P, Tysome J. Prevalence of occult nodal metastases in squamous cell carcinoma of the temporal bone: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2022. [PMID: 35562514 DOI: 10.1007/s00405-022-07399-3] [Reference Citation Analysis]
6 Zhong S, Zuo W. Treatment Strategies for Malignancies of the External Auditory Canal. Curr Treat Options Oncol 2022. [PMID: 35167009 DOI: 10.1007/s11864-021-00931-3] [Reference Citation Analysis]
7 Franz L, Zanoletti E, Franchella S, Cazzador D, Favaretto N, Calvanese L, Mazzoni A, Nicolai P, Marioni G. Temporal bone carcinoma: testing the prognostic value of a novel clinical and histological scoring system. Eur Arch Otorhinolaryngol 2021;278:4179-86. [PMID: 33231758 DOI: 10.1007/s00405-020-06489-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Saijo K, Ueki Y, Tanaka R, Yokoyama Y, Omata J, Takahashi T, Ota H, Shodo R, Yamazaki K, Togashi T, Okabe R, Matsuyama H, Honda K, Sato Y, Morita Y, Takahashi K, Horii A. Treatment Outcome of External Auditory Canal Carcinoma: The Utility of Lateral Temporal Bone Resection. Front Surg 2021;8:708245. [PMID: 34527695 DOI: 10.3389/fsurg.2021.708245] [Reference Citation Analysis]